Obesity Trial, Recruiting NCT07368777 Sponsor: Metropolitan College Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT07368777
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older
  • People with a Body Mass Index (BMI) of 25 or higher (this means a person is considered to be in the "overweight" or above range — the trial site can confirm what this means for a specific situation)
  • People who speak Greek and are able to read and understand Greek well enough to give informed consent
  • People who are willing and able to attend dietary counselling sessions and health assessments for the full length of the study

Who may not be able to join:

  • People who are currently taking any medication for weight loss, such as GLP-1 receptor agonist injections or tablets, appetite suppressants, or other anti-obesity drugs
  • People who have taken part in any organised weight-loss program in the past 3 months, including commercial programs or medically supervised diet plans
  • People who are currently taking medications known to significantly change body weight or body composition, such as steroid tablets (taken regularly throughout the body), antipsychotic medications, or medications for thyroid conditions
  • People who are pregnant or breastfeeding
  • People who have a medical condition that may affect body weight, metabolism, or how the body processes nutrients — for example, untreated thyroid disease, serious digestive disorders, or hormonal conditions

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Angeliki Kapellou, PhD, Dietetics Department, School of Health Sciences, Metropolitan College

Phone: +30 6938406218

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Metropolitan College
Registry
ClinicalTrials.gov
Start date
15 December 2025
Est. completion
1 January 2027

Where this trial is recruiting

🇬🇷 Greece

Primary endpoints

Change in Fat Mass (%)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov